Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAge Labs (BIOA) Non Operating Income (2024 - 2025)

BioAge Labs (BIOA) has disclosed Non Operating Income for 2 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 41.41% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.2 million through Dec 2025, up 71.84% year-over-year, with the annual reading at $12.2 million for FY2025, 71.84% up from the prior year.
  • Non Operating Income hit $2.5 million in Q4 2025 for BioAge Labs, down from $3.0 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $4.2 million in Q4 2024 to a low of -$179000.0 in Q1 2024.